ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2024

Targeting the Epigenetic Marks in Type 2 Diabetes Mellitus: Will Epigenetic Therapy Be a Valuable Adjunct to Pharmacotherapy?

Chioma Laura Odimegwu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.